
	<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
	<ArticleSet>

	<Article> 

	<Journal> 

	<PublisherName>International Science Community Association</PublisherName>

	<JournalTitle>Research Journal of Physical Education Sciences</JournalTitle> 

	<Issn></Issn>

	<Volume>13</Volume>

	<Issue>1</Issue>

	<PubDate PubStatus="ppublish"> 

	<Year>2025</Year> 

	<Month>11</Month> 

	<Day>23</Day> 

	</PubDate>

	</Journal>



	<ArticleTitle>Muscular Dystrophy and Molecular Genetic Analysis</ArticleTitle> 


	<FirstPage>1</FirstPage>

	<LastPage>6</LastPage>



	<ELocationID EIdType="pii"></ELocationID>

	<Language>EN</Language> 
	<AuthorList>

	
		<Author> 

		<FirstName>Makkubhai </FirstName>

		<MiddleName> </MiddleName>

		<LastName>I.M. </LastName>

		<Suffix>1</Suffix>

		<Affiliation>Head Department of Physical Education and Sports, Nehru Arts, Science and Commerce College Hubballi Karnataka, India</Affiliation>

		</Author>

	<Author>

	<CollectiveName></CollectiveName>>

	</Author>

	</AuthorList>


	<PublicationType>Research Article</PublicationType>


	<History>  
	<PubDate PubStatus="received">
	<Year>2025</Year>
	<Month>2</Month>
	<Day>12</Day>
	</PubDate>
	<PubDate PubStatus="accepted">										
	<Year>2025</Year> 
	<Month>11</Month>									
	<Day>23</Day> 
	</PubDate>

	</History>
	<Abstract>Muscular dystrophy (MD) comprises a group of genetically inherited disorders characterized by progressive muscle weakness and degeneration. Understanding the underlying molecular genetic mechanisms associated with different forms of MD is essential for accurate diagnosis, prognosis, and the development of targeted therapeutic interventions. This research paper provides a comprehensive review of the current understanding of MD, focusing on the molecular genetic analysis techniques employed in its diagnosis and characterization. Various genetic testing methods, including next-generation sequencing (NGS), polymerase chain reaction (PCR), and multiplex ligation-dependent probe amplification (MLPA), are discussed in the context of identifying causative mutations and elucidating genotype-phenotype correlations. Advances in molecular genetic analysis have revolutionized the diagnosis and classification of MD, enabling the identification of specific gene mutations responsible for different subtypes of the disease. Through molecular genetic testing, clinicians can accurately diagnose MD, predict disease progression, and provide personalized treatment strategies tailored to individual patients' genetic profiles. Molecular genetic analysis plays a crucial role in the diagnosis, prognosis, and management of muscular dystrophy. By elucidating the underlying genetic abnormalities associated with MD, clinicians can provide timely and targeted interventions to improve patient outcomes and quality of life. Continued research efforts aimed at further understanding the molecular basis of MD hold promise for the development of novel therapeutic approaches and potential cures for this debilitating condition.</Abstract>

	<CopyrightInformation>Copyright@ International Science Community Association</CopyrightInformation>

	<ObjectList> 
	<Object Type="keyword">
	<Param Name="value"></Param>
	</Object>

	</ObjectList>	

	</Article>

	</ArticleSet>
	